all-trans-retinyl Palmitate

All-trans-retinyl palmitate is a lipid of Prenol Lipids (PR) class. All-trans-retinyl palmitate is associated with abnormalities such as Wiskott-Aldrich Syndrome.

Cross Reference

Introduction

To understand associated biological information of all-trans-retinyl Palmitate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with all-trans-retinyl Palmitate?

all-trans-retinyl Palmitate is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with all-trans-retinyl Palmitate

MeSH term MeSH ID Detail
Edema D004487 152 associated lipids
Weight Gain D015430 101 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with all-trans-retinyl Palmitate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with all-trans-retinyl Palmitate?

There are no associated biomedical information in the current reference collection.

What functions are associated with all-trans-retinyl Palmitate?

There are no associated biomedical information in the current reference collection.

What lipids are associated with all-trans-retinyl Palmitate?

There are no associated biomedical information in the current reference collection.

What genes are associated with all-trans-retinyl Palmitate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with all-trans-retinyl Palmitate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with all-trans-retinyl Palmitate

Download all related citations
Per page 10 20 50 100 | Total 736
Authors Title Published Journal PubMed Link
Issing WJ et al. [High concentrate A-mulsin, a new therapy concept in laryngeal leukoplakia]. 1996 Laryngorhinootologie pmid:8851116
Pimstone SN et al. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers. 1996 J. Lipid Res. pmid:8864951
Fex GA et al. Serum retinoids in retinitis pigmentosa patients treated with vitamin A. 1996 Graefes Arch. Clin. Exp. Ophthalmol. pmid:8871145
Piersma AH et al. Teratogenicity of a single oral dose of retinyl palmitate in the rat, and the role of dietary vitamin A status. 1996 Pharmacol. Toxicol. pmid:8884871
Apgar J et al. Reproducibility of relative dose response (RDR) test and serum retinol and retinyl ester concentrations in children after a 2-week interval. 1996 J Am Coll Nutr pmid:8892170
Reinersdorff DV et al. Plasma kinetics of vitamin A in humans after a single oral dose of [8,9,19-13C]retinyl palmitate. 1996 J. Lipid Res. pmid:8895053
Mata NL et al. Comparison of retinyl ester hydrolase activities in bovine liver and retinal pigment epithelium. 1996 J. Lipid Res. pmid:8895060
Goodman GE et al. The association between participant characteristics and serum concentrations of beta-carotene, retinol, retinyl palmitate, and alpha-tocopherol among participants in the Carotene and Retinol Efficacy Trial (CARET) for prevention of lung cancer. 1996 Cancer Epidemiol. Biomarkers Prev. pmid:8896893
Omenn GS et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. 1996 J. Natl. Cancer Inst. pmid:8901853
Issing WJ et al. Long-term follow-up of larynx leukoplakia under treatment with retinyl palmitate. 1996 Nov-Dec Head Neck pmid:8902570